New Delhi : The Delhi High Court has barred the export of generic kidney and liver cancer medication, Sorefenat, manufactured by Natco Pharma Ltd on the plea of German drug major Bayer Corporation.
Justice Manmohan, however, gave liberty to Natco to seek the court’s permission to export the drug as and when it gets the nod from the Drug Controlling Authority.
The court also issued notice to the Centre, customs authorities and Natco, seeking their replies on the plea of Bayer which has alleged that the generic drug is being made under compulsory licence for sale in India and thus, it cannot be exported.
Bayer has sought directions to the customs authorities to seize and confiscate the consignment.
Bigg Boss 19: Who Will Win Ticket To Finale, Ashnoor Kaur, Pranit More, Gaurav Khanna Or Farrhana Bhatt?
Celina Jaitly Shares 15-Year-Old Wedding PHOTO As She Files Domestic Violence Complaint Against Husband Peter Haag
Viral Video: Schoolgirl Turns Fire Drill Into Action-Movie Moment With Bold Smoke Pose
Gold Jumps To ₹1.28 Lakh Per 10 Grams In Delhi, Strong Festive & Wedding Demand Lifts Prices Sharply
